Tema Cardiovascular and Metabolic ETF
Tema Cardiovascular and Metabolic ETF (HRTS) stock FAQs
Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.
What is Tema Cardiovascular and Metabolic ETF (HRTS) stock price today?
As of Jan 14, 2026, 9:00 PM UTC, Tema Cardiovascular and Metabolic ETF (HRTS) stock is trading at $36.24. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date HRTS stock quotes for informed trading decisions.
What is Tema Cardiovascular and Metabolic ETF's market capitalization?
Tema Cardiovascular and Metabolic ETF (HRTS) has a market capitalization of approximately $54.9M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Tema Cardiovascular and Metabolic ETF's size relative to other companies in the USD market. The market cap figure updates automatically as the HRTS stock price changes.
What is the 52-week range for Tema Cardiovascular and Metabolic ETF stock?
Tema Cardiovascular and Metabolic ETF (HRTS) stock has traded in a 52-week range of $25.32 — $36.63. The 52-week range shows the highest and lowest prices at which HRTS traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Tema Cardiovascular and Metabolic ETF stock price to this range provides context for recent price action.
How much trading volume does Tema Cardiovascular and Metabolic ETF stock have?
Tema Cardiovascular and Metabolic ETF (HRTS) stock recently traded approximately 1.3K shares. Trading volume indicates market liquidity and investor interest in HRTS. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Tema Cardiovascular and Metabolic ETF stock.
Does Tema Cardiovascular and Metabolic ETF pay dividends to shareholders?
Yes, Tema Cardiovascular and Metabolic ETF (HRTS) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Tema Cardiovascular and Metabolic ETF stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.
What is Tema Cardiovascular and Metabolic ETF's intraday price range?
Today, Tema Cardiovascular and Metabolic ETF (HRTS) stock has traded in a range of $36.05 — $36.24. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring HRTS's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.
Where does AlphaPilot get Tema Cardiovascular and Metabolic ETF stock data?
AlphaPilot sources real-time HRTS stock quotes, fundamental financial data, and historical price charts for Tema Cardiovascular and Metabolic ETF from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Tema Cardiovascular and Metabolic ETF stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of HRTS stock performance.